Clinical Trial Supply & Logistics Market Analysis | CMI

1

• Coherent Market Insights
• Market Research and Business Consulting Services
• https//www.coherentmarketinsights.com/
• COVID-19 Impact Tracker

2
CLINICAL TRIAL SUPPLY LOGISTICS MARKET ANALYSIS

• Clinical Trial Supply and Logistics Market, By
  Service (Manufacturing, Packaging and Labeling,
  and Distribution), By End User (Pharmaceutical,
  Medical Devices, and Biologics), and by Region -
  Global Forecast to 2026
• The global clinical trial supply and logistics
  market size was valued at US 14.95 Bn in 2017
  and is expected to witness a CAGR of 7.1 over
  the forecast period (2018 2026).

3
Fig Global Clinical Trial Supply and Logistics
Market, By Region (US Mn)
4
Market Drivers

• Quantity of ancillary supplies and diverse
  vendors to produce those supplies have
  significantly increased in the market, owing to
  rising demand for developing and producing
  clinical supplies from end user manufacturers or
  investigators for global studies in a
  cost-efficient manner. According to an article
  published in the Applied Clinical Trials website,
  2016, there are around 40,000 unique
  investigators worldwide conducting at least one
  FDA-regulated clinical trial. Furthermore,
  increasing prevalence of cancer across the globe
  is providing new opportunities for global
  biopharmaceutical research community, and
  clinical trial supply and logistics management to
  bring the respective drug to the market sooner by
  navigating the complex clinical regulatory
  environment. According to the World Health
  Organization (WHO), there were around 555,318 new
  cases of cancer in 2012 in the Middle East. The
  region is expected to witness around 961,098
  cases by 2030, which will be the highest number
  of cancer cases among other regions in the world.

5

• Change in regulations related to clinical trials
  is also expected to have some impact on the
  market. In 2013, the European Union enacted good
  distribution practices (GDPs), which are now
  becoming a globally adopted guidance. Although
  the timeline is still under discussion, new
  regulations for clinical trials that are
  conducted in the European Union will be revealed
  in 2019. The new regulations could potentially
  impact the supply chain, although it is primarily
  geared to existing good manufacturing practices
  (GMPs) for products covered by an existing
  directive.
• Biologics are also expected to witness steady
  growth, owing to increasing research activities
  such as development of nanoparticle-based drug
  delivery systems in the field of genetics and
  biotechnology. For instance, in May 2018,
  Catalent Pharma Solutions collaborated with
  Valerius Biopharma AG, a Swiss biopharmaceutical
  company, for the development and manufacturing of
  Valerius biosimilar products, as alternatives to
  high-priced biologics. This is expected to boost
  Clinical Trial Supply and Logistics Market growth
  over the forecast period.

6
Clinical Trial Supply and Logistics Market
Regional Outlook

• On the basis of region, the global clinical trial
  supply and logistics market is segmented into
  North America, Europe, Asia Pacific, Latin
  America, Middle East, and Africa.
• North America is expected to hold a dominant
  position in this market, owing to the adoption of
  technologically advanced products, well
  established regulatory agencies, and presence of
  major Contract Research Organizations (CROs) and
  biopharmaceutical companys hubs. Moreover,
  factors such as improved healthcare facilities
  and better reimbursement scenario are also
  driving growth of clinical trial supply and
  logistics market in this region.
• The number of new vendors trying to enter the
  healthcare industry are expected to increase over
  the forecast period, as there are many niche
  market players trying to leverage the market
  share through new inventories in medical devices
  and drugs. Also, they will require clinical trial
  supply management to cut down costs across all
  aspects of the business, by reducing internal
  capacity - in terms of site maintenance and
  employee headcount. Thus, emerging economies such
  as Asia Pacific and Latin America has huge
  potential for market growth, and is projected to
  be the fastest growing region over the forecast
  period.

7
Key Players

• Some of the key players operating in the global
  clinical trial supply and logistics market
  include Catalent Pharma Solutions, Inc., Almac
  Group, Movianto, Patheon, Inc., PCI Pharma
  Distribution, Sharp Packaging Distribution,
  PAREXEL International Corporation, Marken, KLIFO
  A/S, and Biocair.

8

• Request Sample Report
• Request Customization
• Download PDF Brochure
• Talk to Analyst
• Reference https//www.coherentmarketinsights.com
  /market-insight/clinical-trial-supply-and-logistic
  s-market-1798

9
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions.
• What we provide
• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

10
Contact Us

• Mr. Shah
• Coherent Market Insights Pvt.Ltd.
• Address 1001 4th Ave, 3200 Seattle, WA 98154,
  U.S.
• Phone [phone]
• Email sales_at_coherentmarketinsights.com

11

• Thank You!
• Kindly follow CMI Social Media Profiles
  for the latest company updates
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/